Leflunomide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Leflunomide and local guidelines before prescribing.

DMARD

Mechanism

Inhibits dihydroorotate dehydrogenase blocking lymphocyte proliferation.

Uses

Rheumatoid arthritis, psoriatic arthritis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Diarrhoea, hypertension, hepatotoxicity, neutropenia, neuropathy, interstitial lung disease.

Interactions

Methotrexate additive hepatotoxicity; warfarin effect.

Contraindications and cautions

Liver disease, pregnancy

Monitoring

FBC, LFT, BP

Pregnancy and breastfeeding

Contraindicated; wash-out before conception

Renal and hepatic impairment

Contraindicated in severe hepatic impairment

Overdose and reversal

Cholestyramine wash-out

Special advice

Very long half-life; cholestyramine wash-out in toxicity or pregnancy.

More from the textbook: uses, cautions and other points
Where it is discussed in the book